Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 0.3033 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase E(z) | 0.0209 | 1 | 1 |
Schistosoma mansoni | enhancer of zeste ezh | 0.0209 | 1 | 1 |
Trypanosoma brucei | polo-like protein kinase | 0.0097 | 0.3033 | 0.5 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0097 | 0.3033 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 0.3033 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 0.3033 | 1 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0097 | 0.3033 | 0.5 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0097 | 0.3033 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0097 | 0.3033 | 0.2978 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 0.3033 | 1 |
Giardia lamblia | Kinase, PLK | 0.0097 | 0.3033 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 0.3033 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0097 | 0.3033 | 0.5 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0097 | 0.3033 | 0.5 |
Loa Loa (eye worm) | SET domain-containing protein | 0.0209 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 0.3033 | 1 |
Echinococcus granulosus | histone lysine N methyltransferase Ez | 0.0209 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0097 | 0.3033 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.738 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.785 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.768 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.706 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.689 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.687 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.674 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.651 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.649 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.578 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.459 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.